vs

Side-by-side financial comparison of ISABELLA BANK CORP (ISBA) and Invivyd, Inc. (IVVD). Click either name above to swap in a different company.

ISABELLA BANK CORP is the larger business by last-quarter revenue ($21.2M vs $17.2M, roughly 1.2× Invivyd, Inc.). ISABELLA BANK CORP runs the higher net margin — 22.2% vs -64.3%, a 86.5% gap on every dollar of revenue. On growth, Invivyd, Inc. posted the faster year-over-year revenue change (24.5% vs 14.3%).

The Bank of the Philippine Islands is a universal bank in the Philippines. It is the oldest bank in both the Philippines and Southeast Asia. It is the fourth largest bank in terms of assets, the second largest bank in terms of market capitalization, and one of the most profitable banks in the Philippines.

Invivyd, Inc. is a clinical-stage biopharmaceutical company focused on developing broadly neutralizing antibody therapies to prevent and treat serious viral infectious diseases. Its core research and development pipeline targets high-burden respiratory pathogens including respiratory syncytial virus, catering to unmet medical needs of global patient groups.

ISBA vs IVVD — Head-to-Head

Bigger by revenue
ISBA
ISBA
1.2× larger
ISBA
$21.2M
$17.2M
IVVD
Growing faster (revenue YoY)
IVVD
IVVD
+10.2% gap
IVVD
24.5%
14.3%
ISBA
Higher net margin
ISBA
ISBA
86.5% more per $
ISBA
22.2%
-64.3%
IVVD

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ISBA
ISBA
IVVD
IVVD
Revenue
$21.2M
$17.2M
Net Profit
$4.7M
$-11.1M
Gross Margin
Operating Margin
32.2%
-73.0%
Net Margin
22.2%
-64.3%
Revenue YoY
14.3%
24.5%
Net Profit YoY
17.4%
40.0%
EPS (diluted)
$0.64
$0.02

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ISBA
ISBA
IVVD
IVVD
Q4 25
$21.2M
$17.2M
Q3 25
$20.5M
$13.1M
Q2 25
$18.8M
$11.8M
Q1 25
$18.1M
$11.3M
Q4 24
$18.5M
$13.8M
Q3 24
$18.0M
$9.3M
Q2 24
$17.2M
$2.3M
Q1 24
$16.7M
$0
Net Profit
ISBA
ISBA
IVVD
IVVD
Q4 25
$4.7M
$-11.1M
Q3 25
$5.2M
$-10.5M
Q2 25
$5.0M
$-14.7M
Q1 25
$3.9M
$-16.3M
Q4 24
$4.0M
$-18.4M
Q3 24
$3.3M
$-60.7M
Q2 24
$3.5M
$-47.2M
Q1 24
$3.1M
$-43.5M
Operating Margin
ISBA
ISBA
IVVD
IVVD
Q4 25
32.2%
-73.0%
Q3 25
30.7%
-84.0%
Q2 25
32.8%
-127.8%
Q1 25
26.9%
-149.7%
Q4 24
26.0%
-139.1%
Q3 24
21.3%
-670.0%
Q2 24
23.9%
-2175.2%
Q1 24
21.8%
Net Margin
ISBA
ISBA
IVVD
IVVD
Q4 25
22.2%
-64.3%
Q3 25
25.6%
-79.7%
Q2 25
26.7%
-124.4%
Q1 25
21.9%
-144.1%
Q4 24
21.6%
-133.5%
Q3 24
18.2%
-653.1%
Q2 24
20.3%
-2086.9%
Q1 24
18.7%
EPS (diluted)
ISBA
ISBA
IVVD
IVVD
Q4 25
$0.64
$0.02
Q3 25
$0.71
$-0.06
Q2 25
$0.68
$-0.12
Q1 25
$0.53
$-0.14
Q4 24
$0.54
$-0.14
Q3 24
$0.44
$-0.51
Q2 24
$0.46
$-0.40
Q1 24
$0.42
$-0.38

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ISBA
ISBA
IVVD
IVVD
Cash + ST InvestmentsLiquidity on hand
$26.0M
$226.7M
Total DebtLower is stronger
Stockholders' EquityBook value
$231.4M
$241.5M
Total Assets
$2.2B
$276.9M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ISBA
ISBA
IVVD
IVVD
Q4 25
$26.0M
$226.7M
Q3 25
$161.3M
$85.0M
Q2 25
$108.6M
$34.9M
Q1 25
$69.2M
$48.1M
Q4 24
$24.5M
$69.3M
Q3 24
$27.4M
$106.9M
Q2 24
$23.6M
$147.9M
Q1 24
$25.2M
$189.4M
Stockholders' Equity
ISBA
ISBA
IVVD
IVVD
Q4 25
$231.4M
$241.5M
Q3 25
$227.4M
$93.1M
Q2 25
$220.5M
$42.8M
Q1 25
$215.6M
$54.1M
Q4 24
$210.3M
$67.5M
Q3 24
$213.0M
$83.2M
Q2 24
$202.2M
$140.6M
Q1 24
$200.7M
$178.5M
Total Assets
ISBA
ISBA
IVVD
IVVD
Q4 25
$2.2B
$276.9M
Q3 25
$2.3B
$139.2M
Q2 25
$2.2B
$89.1M
Q1 25
$2.1B
$103.7M
Q4 24
$2.1B
$129.5M
Q3 24
$2.1B
$161.9M
Q2 24
$2.1B
$177.3M
Q1 24
$2.1B
$215.5M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ISBA
ISBA
IVVD
IVVD
Operating Cash FlowLast quarter
$26.8M
$-15.5M
Free Cash FlowOCF − Capex
$23.3M
FCF MarginFCF / Revenue
110.2%
Capex IntensityCapex / Revenue
16.4%
0.0%
Cash ConversionOCF / Net Profit
5.72×
TTM Free Cash FlowTrailing 4 quarters
$36.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ISBA
ISBA
IVVD
IVVD
Q4 25
$26.8M
$-15.5M
Q3 25
$2.7M
$-8.3M
Q2 25
$7.8M
$-13.3M
Q1 25
$4.7M
$-21.1M
Q4 24
$19.6M
$-37.6M
Q3 24
$3.6M
$-41.1M
Q2 24
$5.5M
$-41.6M
Q1 24
$3.4M
$-50.2M
Free Cash Flow
ISBA
ISBA
IVVD
IVVD
Q4 25
$23.3M
Q3 25
$1.7M
Q2 25
$7.2M
$-13.3M
Q1 25
$3.7M
$-21.3M
Q4 24
$17.5M
$-37.6M
Q3 24
$3.2M
$-41.1M
Q2 24
$5.1M
Q1 24
$2.6M
$-50.4M
FCF Margin
ISBA
ISBA
IVVD
IVVD
Q4 25
110.2%
Q3 25
8.5%
Q2 25
38.5%
-112.9%
Q1 25
20.6%
-188.2%
Q4 24
94.6%
-272.2%
Q3 24
17.7%
-441.6%
Q2 24
29.8%
Q1 24
15.7%
Capex Intensity
ISBA
ISBA
IVVD
IVVD
Q4 25
16.4%
0.0%
Q3 25
5.0%
0.0%
Q2 25
3.2%
0.1%
Q1 25
5.5%
1.3%
Q4 24
11.4%
0.0%
Q3 24
2.0%
0.1%
Q2 24
2.4%
0.0%
Q1 24
4.9%
Cash Conversion
ISBA
ISBA
IVVD
IVVD
Q4 25
5.72×
Q3 25
0.52×
Q2 25
1.56×
Q1 25
1.19×
Q4 24
4.91×
Q3 24
1.08×
Q2 24
1.59×
Q1 24
1.10×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons